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Abstract
Leishmania is the causative protozoan parasite of leishmaniasis. Distinct species provoke 
localized/diffuse cutaneous leishmaniasis or visceral leishmaniasis. Leishmania parasites 
have developed diverse strategies to evade the host immune response expressed through 
various cells, especially macrophages, NK cells, and dendritic cells. Participating in some 
of these strategies are Leishmania surface molecules, such as lipophosphoglycan (LPG) and 
protease gp63, which are thus considered virulence factors. LPG has been shown to modu-
late proinflammatory responses. For example, L. major LPG activates NK cells through toll-
like receptor-2 (TLR2), while L. mexicana LPG elicits a differential production of cytokines in 
human dendritic cells and monocytes. Moreover, L. mexicana LPG activates MAP kinases in 
macrophages, which in turn enhance proinflammatory cytokine production through TLRs. 
Additionally, Leishmania exosomes have been found to strongly affect macrophage signal-
ing and functions. Furthermore, proteins secreted by Leishmania promastigotes and amas-
tigotes modulate the production of proinflammatory cytokines in human macrophages. 
Since Leishmania is an obligate intracellular parasite, its promastigotes utilize several mech-
anisms to survive and duplicate inside host cells, including the inhibition of apoptosis. It is 
now clear that MAPK p38, JNK, ERK 1/2, and PI3K/Akt participate in the inhibition of both 
natural and induced apoptosis of macrophages, neutrophils, and dendritic cells.
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1. Introduction
Leishmaniasis is a complex of neglected tropical diseases (NTDs) caused by protozoan para-
sites of the genus Leishmania. Epidemiological studies have revealed that 12 million people are 
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infected worldwide, with 2 million new cases each year. Approximately 350 million people are 
currently at risk of contracting leishmaniasis, mostly in developing countries.
Leishmania is a dimorphic protozoan parasite that completes its life cycle in two organisms: the 
sand fly vector and a mammalian host (a rodent, canid, or human). In the vector, the parasite 
enters the insect as aflagellated amastigotes through a blood meal from a mammal. In the sand 
fly midgut, this form changes into motile extracellular flagellated promastigotes that divide by 
binary fission. After being injected into the bloodstream of a mammalian host, the promasti-
gotes are quickly engulfed by macrophages, where they differentiate into aflagellated intracel-
lular amastigotes that can survive in this acidic environment. In macrophages, the amastigotes 
replicate by binary fission, causing the lysis of the cell and the invasion of other cells [1].
The outcome of a Leishmania infection depends on a wide array of factors, especially the species 
of the parasite and the host immune response. Species such as L. major, L. mexicana and L. guya-
nensis induce cutaneous leishmaniasis, while L. amazonensis and L. braziliensis cause the mucocu-
taneous form. L. donovani and L. chagasi, on the other hand, cause visceral leishmaniasis (VL) [2].
Whether Leishmania parasites manage to establish themselves in mammalian cells depends on 
their capacity to surpass host defense mechanisms. The survival strategies of the protozoan are 
based on the manipulation of distinct host cell functions, including modulation of cell signal-
ing pathways through phosphorylation and dephosphorylation mechanisms [3]. The different 
strategies of Leishmania to evade the host immune response during the process of infection 
involve macrophages, NK cells, and dendritic cells. One of the most successful survival strate-
gies displayed by Leishmania is the inhibition of apoptosis of host cells through the activation or 
silencing of proapoptotic or antiapoptotic signaling pathways [4, 5]. Among the Leishmania sur-
face components participating in such evasion strategies is lipophosphoglycan (LPG), an abun-
dant molecule that exerts its activity by binding to TLR2. Although the ability of Leishmania to 
inhibit inflammatory signaling pathways has been proposed as a virulence mechanism, the 
molecular events underlying this process have still not been fully elucidated [6].
2. Parasite molecules that regulate host cell signaling pathways
Two of the most studied molecules of Leishmania spp. are LPG and glycoprotein 63 (gp63), pos-
tulated as possible virulence factors for some species. LPG covers the surface of the parasite and 
the flagellum, forming a glycocalyx. The structure of LPG, which differs between the distinct 
species of Leishmania, is mainly constituted by repeating units of a disaccharide and a phosphate 
bound to the membrane by glycosylphosphatidylinositol (GPI). This molecule is more abun-
dant in promastigotes than amastigotes [7]. Contrarily, gp63 is more frequently expressed in 
amastigotes than promastigotes. The absence of LPG in amastigotes emphasizes the relevance of 
gp63 in protozoan survival, as well as in the regulation of signaling pathways of host cells [8, 9].
Other important molecules for Leishmania are glycosylinositolphospholipids (GPILs), a class 
of glycolipids bound by GPIs and expressed 10 times more frequently than LPG. Their small 
size keeps them close to the parasite membrane [10, 11].
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The term “secretome” was introduced for the first time in the global study of the genome of 
proteins secreted by Bacillus subtilis. The authors defined the secretome as a subset of the pro-
teome consisting of secreted proteins and the components of the cellular machinery involved in 
protein secretion. They predicted all exported B. subtilis proteins by employing computational 
methods to search for signal peptides and cellular retention signals in protein sequences [12]. In 
Plasmodium falciparum, the secretome refers to all proteins exported to the host erythrocyte and 
mediated by an endoplasmic reticulum signal sequence, along with one export element of this 
parasite [13, 14]. Until very recently, there was very little information about the proteins secreted 
by protozoan parasites. Given the role of these proteins as virulence factors and their capacity to 
modulate host cells, this scant information represented an important scientific limitation.
Regarding trypanosomatids, the term secretome was introduced by Silverman in a pro-
teomics approach used to identify a large number of extracellular proteins in a culture media 
conditioned by L. donovani [15]. Several studies on trypanosomatids have aimed to identify 
and characterize excreted/secreted factors due to their potential for the development of vac-
cines and/or new drugs [16].
Leishmania and other intracellular pathogens have developed strategies to invade and persist 
within the respective host cell. In some cases, the mechanisms entail the export of virulence 
factors to the cytosol of this same cell [15]. Almost a decade has passed since the first report 
of the secretion proteins by L. donovani. By means of a stable isotope label of amino acids 
in a culture called SILAC, the authors identified 151 proteins secreted by this species into 
the culture media. Interestingly, few of these are secreted through classical mechanisms [15]. 
Additionally, the bioinformatic analysis in the same study showed that none of the histidine 
phosphatase proteins result from the classical mechanism of secretion.
The authors found various proteins with several possible functions. For instance, some pro-
teins take part in the vesicular transport process, essential for the survival of the parasite, and 
may thus be virulence factors. Among the proteins participating in signal transduction are 
those encoded by the gene LmjF 25.0750 of L. major, including a phosphatase serine threonine 
type phosphoprotein, a metal-dependent phosphatase (PPM) called PP2C [15]. This protein 
was cloned from the DNA genome of L. major and localized in the pocket and flagellum of the 
parasite through fluorescence microscopy assays and transmission electron microscopy [3].
Since the flagellum of L. major represents an important structure for differentiation in try-
panosomatids, this location of PP2C suggests a role in a vital biological process of the parasite 
[3]. The same authors have shown that L. mexicana promastigotes and amastigotes secrete pro-
teins with phosphatase activity into the culture medium. Such activity was more pronounced 
in the promastigote than amastigote secretion medium. Both media stimulated the produc-
tion of various cytokines in human macrophages: tumor necrosis factor (TNF)-α, interleukin 
(IL)-1β, IL-12p70, and IL-10 [17].
2.1. Exosomes secreted by Leishmania
Exosomes are organelles (30–100 nm) released by numerous mammalian cells, including retic-
ulocytes, B cells, T cells, dendritic cells, and macrophages [18]. Bioactive exosomes are released 
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by cells infected with viruses and bacteria as well as some tumor cells [19, 20]. The release of 
exosomes also constitutes a mechanism for the secretion of proteins by Leishmania, and these 
vesicles allow for communication with the host cell [15]. Among the proteins released through 
exosomes, the metalloprotease 63 kDa and the elongation factor 1 alpha (EF-1 α) are known 
to have a substantial role in deregulating certain signaling pathways. These two molecules, 
contained in microvesicles, are responsible for the activation of tyrosine phosphatases (SHP-1) 
in the host cell [21]. A study of L. mexicana demonstrated a type of vesicle induced at a tem-
perature of 37°C that did not correspond to exosomes, as evidenced by its size.
Other studies confirm a nonclassical route of secretion for Leishmania proteins. Two-dimen-
sional electrophoresis displayed 270 secreted protein spots originating from L. braziliensis, 
of which 42 were identified. About 57% of these proteins presented non-classical secretion 
mechanisms [22].
In L. infantum, distinct proteins were observed in exovesicles of the parasites in the different 
phases of their growth. Ribosomal proteins were detected in the logarithmic phase of growth, 
thus indicating their crucial role in protein turnover. In the stationary phase, contrarily, there 
was a specific enrichment of vesicles with properties similar to apoptotic vesicles [23].
Diverse Leishmania species have been analyzed to explore the effect exerted by their secreted 
molecules on the host immune response. For example, in infection by L. donovani and inter-
feron (IFN)-γ treatment, the exposure of human monocytes to the exosomes secreted by this 
parasite led to an alteration in the cytokine response. The resulting inhibition of IL-8 and 
TNF-α production combined with enhanced levels of IL-10 caused an anti-inflammatory 
effect. This immune suppression induced during Leishmania infection suggests that the secre-
tion of exosomes by Leishmania likely plays a major role in the establishment of infection. 
Indeed, exosomes may be a mechanism of immune modulation used more generally by intra-
cellular and extracellular pathogens [24].
3. Leishmania modulates proinflammatory cytokines, 
inflammasomes, and TLR expression
To detect Leishmania infections, the innate immune system utilizes different sets of germline-
encoded receptors, including the TLRs found on cell membranes and in the endosome. Other 
receptors that have only been detected in the cytoplasm, such as the NOD-like receptor (NLR) 
family, also play a role in defending the host from a Leishmania invasion. Encompassing 34 
members in all, NLRs sense pathogen- and danger-associated molecular patterns (PAMPs 
and DAMPs, respectively).
There is a subset of NLRs that assembles large multiprotein complexes known as inflamma-
somes. The latter trigger inflammatory caspase 1, which in turn promotes the conversion of 
pro–IL-1β and pro–IL-18 into their bioactive forms. For instance, NLRP3 (the best-character-
ized inflammasome) consists of the NLRP3 protein, the bipartite adaptor protein ASC, and 
caspase 1 (in its minimum form). It has been demonstrated that this inflammasome, activated 
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by bacterial toxins, bacterial RNA, ATP, nigericin, uric acid, and silica crystals, is an essential 
component of the host immune response against bacterial and viral pathogens [25].
Leishmania parasites have developed diverse strategies to evade the immune response, 
especially in the form of macrophages, NK cells, and dendritic cells. Becker analyzed the 
interaction between Leishmania LPG and TLR2 receptors on human NK cells, finding that 
LPG purified from metacyclic and procyclic promastigotes of L. major stimulates these host 
cells. The consequent activation of NK cells leads to an upregulation of TLR2 expression, the 
nuclear translocation of NF-κB, and an increased production of IFN-γ and TNF-α. Indeed, 
the activation of NK cells turned out to be greater with the infective metacyclic form than the 
non-infective procyclic form of LPG [26].
L. mexicana LPG elicits a differential production of proinflammatory cytokines, such as IL-12, 
TNF-α and IL-10, as well as the nuclear translocation of NF-κB in monocytes and dendritic 
cells [27]. It also activates ERK and p38 MAP kinase in macrophages and induces proinflam-
matory cytokine production through TLR2 and TLR4 signaling [28].
After infecting the THP1 human cell line with L. donovani, the production of IL-10, TNF-α and 
IFN-γ was measured, and the expression of TLR2, TLR4, and TLR9 was determined in blood 
samples and the THP1 cell line. IL-10 levels were higher in controls positive to the leishmanin 
skin test (LST+) compared to patients with VL. TNF-α was moderately produced, exhibiting 
no variation between patients, controls, and THP1 cells. TLR4 and TLR9 expression was ele-
vated in patients with VL. L. donovani increased the expression of TLR4 and TLR9 in patients 
with VL, and of TLR2 in THP1 cells, which suggests a link between TLRs and the generation 
of a mixed cytokine response [29].
Interestingly, other authors analyzed the expression of some components related to the 
inflammasome pathway in murine macrophages infected with L. major. At 6 and 18 h post 
infection, they evaluated the mRNA expression levels in control and infected macrophages 
of two NLRs (NLRP3 and NAIP5), the inflammasome adaptor molecule ASC, proinflam-
matory caspase-1, and proinflammatory cytokines IL-1β and IL-18. The components related 
to the inflammasome pathway (NLRP3, ASC, IPAF, IL-1β, and IL-18) were upregulated in 
murine macrophages infected with L. major. The activity of caspase-1 was more pronounced 
in infected than noninfected macrophages. Infected (versus uninfected) macrophages also 
showed significantly greater caspase-1 activity in harvested cells and a significantly higher 
concentration of IL-1β in the supernatant of the cultured media [30].
It has been documented, based on in vitro (in macrophages) and in vivo studies, that a 
Leishmania infection activates the NLRP3 inflammasome and that the latter is key to the inhi-
bition of parasite replication. For example, the capacity of inflammasome-deficient mice to 
resist infection with L. amazonensis, L. braziliensis, L. infantum, and L. chagasi was favored by 
IL-1β production resulting from inflammasome activation. The mechanism involved in such 
activation was the increase in the level of nitric oxide (NO), which in turn was mediated 
by the elevated availability of nitric oxide synthase NOS2 resulting from signaling through 
the IL-1 receptor and MyD88. Lima-Junior et al. previously showed that the NLR3 inflam-
masome is vital for the host response to L. amazonensis infection, having proven to restrict 
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parasite replication in both isolated macrophages and in vivo. As can be appreciated, IL-1β 
production is involved in the host resistance to infection. The signaling that triggers the pro-
duction of this cytokine takes place through the IL-1 receptor and MyD88, contributing to 
elevated levels of NOS2. An increase in the latter enzyme leads to a greater generation of NO, 
a major host defense mechanism against Leishmania spp. [31].
In the case of L. major, secreted antigens suppressed the proliferation of BALB/c mice lym-
phocytes in vitro. After semi-purifying these secreted antigens, they were found to suppress 
60% of lymphocyte proliferation and prevent the stimulation of lymphocytes. The fractions 
obtained decreased the production of IFN-γ and increased the level of IL-4 in lymphocytes, 
whereas they downregulated the formation of NO by activated macrophages. Hence, pro-
teins secreted by L. major may function as immunosuppressive factors that downregulate the 
immune system [32]. On the other hand, the immunomodulatory effect of proteins excreted/
secreted by L. infantum was described in the context of differentiation and maturation of 
human dendritic cells [33].
Regarding L. donovani, an immunomodulatory role has also been established for leishmanial 
excretory-secretory antigens (LESAs) released by promastigotes to the culture medium. The 
separation of fractions from LESAs revealed proteins of different molecular weights. Both 
fractions were highly immunogenic, as they significantly enhanced the activity of NADPH 
oxidase and SOD, as well as the production of NO, TNF-α, IFN-γ, and IL-12 in stimulated 
RAW 264.7 macrophages. These results strongly suggest the potential role of LESAs in the 
modulation of macrophage effector functions and Th1 responses, which could possibly be 
used in the development of a potent vaccine for visceral leishmaniasis [34]. Similarly, Kumar 
reported a potential immunostimulatory effect of soluble exogenous antigens of L. donovani, 
which may be instrumental in developing a subunit vaccine against VL [35].
4. Leishmania modulates L-arginine metabolism via NOS2 and 
arginase-1
Among other strategies developed by Leishmania parasites to avoid elimination by the host 
immune response, regulation of L-arginine metabolism via NOS2 and arginase-1 (ARG-1) 
enzymes has emerged as a crucial mechanism for parasite survival. Macrophages, the main 
host cells that battle Leishmania, can be instructed to kill or host intracellular amastigote forms 
of this parasite, depending on their ability to express NOS2 or ARG-1. The expression of these 
enzymes, which share L-arginine as a substrate, is regulated in macrophages by their percep-
tion of the environmental balance of cytokines.
Proinflammatory cytokines (e.g., TNF-α and IFN-γ) induce the classical activation of macro-
phages, upregulating NOS2 expression. This enzyme catalyzes the conversion of L-arginine 
into L-citrulline and NO, the latter molecule being considered the most potent leishmanicidal 
agent for the elimination of intracellular Leishmania parasites [36]. On the other hand, anti-
inflammatory cytokines (e.g., IL-4, IL-10 and IL-13) elicit an alternative activation of macro-
phages that upregulates ARG-1 [37], which in turn catalyzes the conversion of L-arginine into 
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urea and L-ornithine. The latter is a basic source for the synthesis of polyamines, essential 
nutrients for the growth and surveillance of Leishmania [38, 39]. Hence, whether L-arginine 
metabolism takes place through ARG-1 or NOS2 is decisive for the life or death of Leishmania 
during infection [40].
To establish infection and avoid host surveillance, Leishmania parasites have developed 
different strategies to hijack L-arginine metabolism in order to promote the production of 
polyamines rather than NO. During its development inside the vector, for instance, the para-
site generates a mucin-rich gel that sand flies deliver into the host skin when transmitting 
Leishmania promastigotes [41]. This gel, called promastigote secretory gel, is known to mod-
ulate L-arginine metabolism in macrophages [42]. Accordingly, promastigote secretory gel 
stimulates the recruitment of macrophages and promotes their alternative activation, causing 
an increased expression of arginase-1 along with its greater capacity to metabolize L-arginine 
to afford polyamines, which in turn enhance the growth of Leishmania [42].
The parasite-induced upregulation of arginase-1 can affect the production of NO through 
substrate (L-arginine) competition [41]. Additionally, the generation of some polyamines 
resulting from L-arginine metabolism via arginase-1 (e.g., spermine, spermidine and putres-
cine) inhibit NOS2 function [38, 39, 43]. The modulation of L-arginine metabolism is relevant 
not only during the onset of the infection but throughout the course the disease. The success 
of host immunity or the pathology of leishmaniasis depends mainly on the balance of the 
immune response. Since the formation of either NOS2 or arginase leads to the inhibition of 
the other, these two metabolic states are competitive and tightly regulated [44], determining 
the levels of NO and therefore the outcome of Leishmania infection (survival versus elimina-
tion) in the host.
Besides the production of polyamines and the resulting enhancement of Leishmania intra-
cellular growth in alternatively activated macrophages, recently findings have shown that 
Leishmania-induced L-arginine metabolism via ARG-1 polarization is advantageous to the 
parasite in yet another way. A substantial accumulation of alternatively activated macro-
phages causes an elevated demand, consumption, and depletion of L-arginine in the micro-
environment [41]. Since T lymphocytes are very sensitive to L-arginine starvation, a greater 
consumption of this amino acid via ARG-1 limits its availability to T cells, which in turn 
notably impairs the development and function of these cells that are required for the control 
of a Leishmania infection [45, 46].
5. Inhibition of apoptosis
Leishmania is an obligate intracellular parasite that invades a variety of host cells, but it is in 
dendritic cells and macrophages where it can survive and replicate inside the phagosome. The 
condition of being obligate intracellular parasites presupposes the utilization by Leishmania 
of mechanisms to manipulate host cells in order to evade the immune response and survive 
inside cells. Along the evolutionary history of this parasite, diverse survival strategies have 
been developed.
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Although the inhibition of the phagosome-lysosome fusion comprises one such strategy, one 
of the most intriguing is the inhibition of apoptosis. The latter process is a type of programmed 
cell death characterized by a very orderly and immunologically silent dismantling of a cell 
[47, 48]. The activation or inhibition of several signaling pathways is required for apoptosis to 
occur [49–53]. Whereas the initiation of apoptosis involves gene activation and transduction 
pathways, the executioner phase requires the activation of the cellular machinery necessary 
for the dismantling of the cell.
Apoptosis is a crucial defense mechanism against intracellular pathogens [54]. However, 
many pathogenic microorganisms such as virus [55], bacteria [56], and protozoan parasites 
[57, 58] have developed mechanisms to persist within host cells without inducing apoptosis. 
It has been widely documented that Leishmania inhibits apoptosis of different cells such as 
macrophages [59–61], monocytes [64] and neutrophils [66].
Recently, it has been demonstrated that L. mexicana promastigotes and amastigotes also inhibit 
apoptosis in dendritic cells [62, 63]. In some of these studies, monocytes, dendritic cells, and 
macrophages were grown under apoptogenic conditions and infected with different species 
of Leishmania, resulting in the inhibition of normal apoptosis.
In particular, infection with L. donovani or a stimulus with its LPG inhibits apoptosis in mac-
rophages. Cellular activation caused by infection increases the production of TNF-α, TGF-
β, IL-6, and GM-CSF, while decreasing the secretion of M-CSF and IL-1β [60]. Additionally, 
L. major delayed apoptosis by inhibiting the release of mitochondrial cytochrome C in infected 
macrophages grown in the presence of staurosporine [59]. Studies performed on other cell lines 
report a similar outcome, such as the inhibition of actinomycin D-induced apoptosis in the 
monocyte cell line U937 infected with L. infantum [64]. In macrophages from the cell line RAW 
264.7 infected with L. major, apoptosis diminished even in the presence of cycloheximide [65]. 
Exposing neutrophils to L. major led to reduced caspase-3 activity, thus inhibiting spontaneous 
apoptosis [66]. Moreover, amastigotes and promastigotes of L. mexicana inhibited camptothecin-
induced apoptosis in monocyte-derived dendritic cells [62, 63]. In the majority of reports, the 
antiapoptotic effect has been associated with a significant decline in caspase-3 activity in cells.
5.1. Signaling pathways involved in Leishmania-induced inhibition of host cell 
apoptosis
Although Leishmania infection is known to inhibit apoptosis in several cells, the mechanism(s) 
through which this process takes place in infected cells is not fully clear. One signaling path-
way involved in apoptosis is that of MAPKs, a family of serine/threonine kinases. Four major 
pathways have been identified in mammalian cells for signaling by MAPKs: extracellular 
signal-related kinases (ERK1/2), c-Jun amino–terminal kinases (JNK1/2/3), p38 (α, β, γ, δ), 
and ERK5 [67–70]. MAPKs respond to a wide variety of stimuli, such as proinflammatory 
cytokines, environmental stress, DNA damage, and growth factors [50, 71]. The p38 path-
way is associated with cytokine production, inflammation, cell growth and differentiation, 
and cell death. JNK participates in the control of cell death and is encoded by three genes: 
JNK1/SAPKγ, JNK2/SAPKα, and JNK3/SAPKβ. Contrarily, the signaling pathway of PI3K/
AKT has an antiapoptotic role through the phosphorylation of PI3K/AKT that conducts to the 
downstream activation of multiple signaling pathways related to growth, development, and 
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cellular survival processes [72]. MAPKs [73, 74] and PI3K [75] are activated during Leishmania 
infections and participate in the apoptosis or survival cells [76–78].
Diverse signaling pathways have been implicated in the inhibition of apoptosis by Leishmania, 
such as NF-κB, PI3K, and p38 MAPK PI3K. However, only the inhibition of PI3K resulted 
in the abrogation of the antiapoptotic phenotype, whose activation confers apoptosis inhibi-
tion in infected macrophages [79] and dendritic cells [5]. ERK1/2 is activated in neutrophils 
infected with L. major and modulates multiple apoptotic pathways [80]. Contrarily, p38 and 
JNK are deactivated to prevent apoptosis [4, 5]. Survival is mediated by signaling pathways 
(e.g., PI3K/Akt), as well as by the expression of antiapoptotic proteins of the Bcl-2 family (e.g., 
Bcl-2, Bcl-xL, MCL-1, and A1). We have demonstrated that L. mexicana promastigotes and 
amastigotes also inhibit apoptosis in dendritic cells [62, 63] through the downregulation of 
proapoptotic pathways (e.g., MAPK p38 and JNK), as well as the activation of antiapoptotic 
routes such as PI3K/Akt [4, 5].
6. Conclusion
Leishmania parasites have developed diverse strategies to evade the immune response: elici-
tation of a differential production of proinflammatory cytokines, upregulation of TLR2 and 
TLR4 expression, the nuclear translocation of NF-κB, and modulation of inflammasome. 
These parasites have a dual relation with host cells. Whereas host cells provide them with 
nutrients and a place to survive and replicate, these same cells exhibit an immune response 
aimed at the destruction of the parasites. Hence, the latter must display a wide array of strate-
gies to overcome host cells defense mechanisms. One of the most successful strategies utilized 
by Leishmania inside host cells is the inhibition of apoptosis.
Apoptosis is a type of programmed cell death involving a precisely orchestrated series of 
steps that culminate in the orderly dismantling of the cell. This process encompasses the acti-
vation and silencing of a wide variety of signaling pathways, among which a leading role 
is played by MAPK, PI3K/Akt and proapoptotic/antiapoptotic proteins of the Bcl-2 family. 
Leishmania has the capacity to inhibit apoptosis of different cells, especially macrophages, 
monocytes, neutrophils, and dendritic cells. Although the precise mechanisms have not been 
fully elucidated, it is now clear that MAPK p38, JNK, ERK 1/2, and PI3K/Akt participate in 
the inhibition of apoptosis in macrophages, neutrophils, and dendritic cells. The inhibition 
of apoptosis is a key strategy for the survival and replication of Leishmania in host cells and 
may have implications for its pathogenesis because of favoring the invasion of the host and 
the persistence of the parasite in host cells. Further research is needed on the mechanisms of 
activation and regulation of the inflammasome pathway to provide insights into the patho-
physiology of chronic diseases and reveal new therapeutic targets.
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